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Abstract
Background: Erythrocyte-associated antigenic polymorphisms or their absence have perhaps evolved in the
human population to protect against malarial infection. Studies in various populations consistently demonstrate
that blood group ‘O’ confers resistance against severe falciparum infection. In India, Odisha state has one of the
highest incidences of Plasmodium falciparum infection and contributes to the highest number of deaths by
falciparum malaria. This study aims to evaluate the relationship between ABO blood group and severe malaria in
an adult population at the tertiary care centre in Odisha.
Methods: A total of 353 P. falciparum infected subjects and 174 healthy controls were screened for ABO blood
group. Falciparum-infected individuals were categorized as severe malaria and uncomplicated malaria. Severe
malaria was further clinically phenotyped into cerebral malaria, non-cerebral severe malaria and multi-organ
dysfunction. A meta-analysis was performed to assess the role of ABO blood group in severe malaria.
Results: Frequency of blood group ‘B’ was significantly higher in patients with severe malaria compared to the
uncomplicated cases (P < 0.0001; OR = 4.09) and healthy controls (P < 0.0001; OR = 2.79). Irrespective of the level of
clinical severity, blood group ‘B’ was significantly associated with cerebral malaria (P < 0.0001; OR = 5.95), multi-organ
dysfunction (P < 0.0001; OR = 4.81) and non-cerebral severe malaria patients (P = 0.001; OR = 3.02) compared to the
uncomplicated category. Prevalence of ‘O’ group in uncomplicated malaria (P < 0.0001; OR = 2.81) and healthy controls
(P = 0.0003; OR = 2.16) was significantly high compared to severe malaria. Meta-analysis of previous studies, including
the current one, highlighted the protective nature of blood group ‘O’ to severe malaria (P = 0.01). On the other hand,
carriers of blood group ‘A’ (P = 0.04) and ‘AB’ (P = 0.04) were susceptible to malaria severity.
Conclusions: Results of the current study indicate that blood group ‘O’ is associated with reduced and ‘B’ blood
group with increased risk of development of severe malaria in Odisha, India. Meta-analysis also supports the
protective nature of blood group ‘O’ from severe falciparum infection.
Keywords: ABO blood group, severe malaria, cerebral malaria, multi-organ dysfunction, non-cerebral severe malaria,
uncomplicated malaria, meta-analysis
Background
Malaria is an infection caused by protozoan parasites of
the genus Plasmodium and transmitted by the bite of
infected Anopheles mosquitoes. Out of the four species
that infect humans, Plasmodium falciparum is the
principal cause of severe clinical manifestations [1].
Cyto-adherence and rosetting are important components
of several possible pathogenic mechanisms attributed to
the cause of severe infection [2]. An association between
‘O’ blood group and lower rosetting capacity has been
demonstrated [3]. However, rosetting capacities of blood
group ‘A’, ‘B’ or ‘AB’ have remained controversial [4-7].
On the erythrocyte surface, the A and B antigens are
tri-saccharides -A, GalNAca1-3(Fuca1-2)Gal1b1; and B-
Gal1a1-3(Fuca1-2)Galb1 respectively, that are attached
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any medium, provided the original work is properly cited.to different glycolipids and glycoproteins [8]. An enzyme
glucotransferase is necessary for the production of A
and B antigens. On the other hand, blood group ‘O’ car-
ries a disaccharide H antigen (Fuca1-2Galb1) due to the
absence of the enzyme glucotransferase [8]. Variations
in gene encoding functional glucotransferase have been
associated with protections from severe P. falciparum
malaria [9] and this observation has been further
strengthened by a recent genome wide association study
[10]. Tri-saccharide of ‘A’ and ‘B’ blood group is pre-
sumed to act as receptors and functions as an important
factor for rosetting [7]. However, RBCs of blood group
‘O’ do not express tri-saccharide, and rosettes formed by
infected ‘O’ blood group RBCs are smaller and easily
disrupted compared to blood groups A, B or AB
[4,7,11].
There are limited reports in literature on association
of ABO blood group and susceptibility to severe falci-
parum malaria.. The association of blood group ‘AB’
and severe malaria has been demonstrated in various
populations, viz. Sri Lanka [12], Mali [11], and Ethiopia
[1], while a significant association has also been reported
between blood group ‘A’ and severity in Gabon [13],
Ethiopia [1] and Zimbabwe [14]. The role of blood
group ‘B’ and severe falciparum infection has not been
reported.
Malaria remains a major health problem in India. The
National Vector Borne Disease Control Programme
(NVBDCP), India, has reported that 1.8 million cases of
malaria and 1,000 malaria-related deaths occur annually
[15]. However, the World Health Organization (WHO)
estimates that figure to be 20 million cases and 15,000
deaths [16]. A recent study reported a staggering
1,22,000 deaths due to malaria in India, and Odisha as a
major contributor to this mortality [17]. Although the
state is hyper-endemic to P. falciparum malaria [18]
and contributes 29.8% of deaths related to the infection
[15], no study has been carried out in the local popula-
tion to assess the association of ABO blood group in
severe infection. Therefore, the current study aims to
investigate this association and look into the overall role
of ABO blood group in risk/resistance to the develop-
ment of severe malaria by a meta-analysis of results
from the current study and earlier published reports.
Methods
Study site and participants
The study was conducted at S.C.B. Medical College,
Cuttack, Odisha, India between 2008-2009. Patients (age
≥15 years) admitted to the Department of Medicine
with a short history of fever were clinically examined in
detail and screened for P. falciparum infection by
Giemsa-stained thick and thin blood smears and
immune chromatography test (SD Bio Standard
Diagnostics India). Detection of P. falciparum was also
performed by nested polymerase chain reaction (PCR).
Individuals infected only with P. falciparum were
included. Clinical categorization was done based on
WHO guidelines [19]. Uncomplicated malaria (UM) was
defined as patients with fever and evidence of falci-
parum infection in the blood. Severe malaria(SM) was
categorized into three groups based on distinct clinical
features: 1) Cerebral malaria (CM), 2) Non cerebral
severe malaria (NCSM) and 3) Multi-organ-dysfuction
(MOD). CM was further defined as patients with altered
sensorium, GCS (Glasgow Coma Scale) of ≤ 10. NCSM
patients had one of the several manifestations of severe
malaria without cerebral involvement, namely severe
anaemia (haemoglobin <5 g/dl), acute renal failure
(serum creatinine >3 mg/dl), jaundice (serum bilirubin
>3 mg/dl), acute respiratory distress syndrome (PaO2/
FIO2 <200), haemoglobinuria (dark red or black
coloured urine positive for haemoglobin) and shock
(systolic BP of <80 mm Hg). MOD was diagnosed based
on presence of two or more organ involvement like
CNS (GCS≤10), respiratory (PaO2/FIO2 <200), renal
failure (serum creatinine >3 mg/dl) and hepatic dysfunc-
tion (ALT/AST >3 times of normal, prolonged pro-
thrombin time and albuminaemia). 174 healthy controls
(HC) of identical ethnicity and hailing from a similar
geographical background were enrolled. None of the
controls reported history of clinical malaria in the last 5
years. They were essentially healthy and negative for
demonstrable P. falciparum infection. The risk of expo-
sure to malaria was similar for both HC and patients.
Criteria for analysis of mortality: Since death occurred
in the CM and MOD groups’ only patients from these
groups were included for analysis. The study was
approved by the Institutional Ethics Committee of the
Medical College and blood samples were collected after
written consent of the patients or accompanying person,
depending on the clinical scenario.
Polymerase chain reaction
Genomic DNA was extracted by GenElute™ Blood
Genomic DNA Kit (SIGMA) from whole blood accord-
ing to the manufacturer’s instructions. Polymerase chain
reaction (PCR), has been used to detect up to species
level - falciparum, vivax, ovale and malariae [20,21]. In
the population under study, P. falciparum is the major
cause of malaria (>80%) followed by P. vivax (10-15%)
[22]. With slight modification, genus and species specific
nested PCR technique was used to detect P. falcipaurm
and/or P. vivax infections [20]. In brief, primary PCR
(to detect Plasmodium genus) was performed in a 20 μl
PCR reaction containing 3 μLg e n o m i cD N A ,1 ×T a q
buffer containg MgCl2 (SIGMA), 250 μMd N T P
(SIGMA)), 200 nM of two genus-specific primer rPLU1
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rPLU5 (5’-CCT GTT GTT GCC TTA AAC TCC-3’)
(Integrated DNA technologies) and 1 U of DNA poly-
merase (SIGMA). The cycle conditions were as follows:
an initial de-naturation step at 95°C for 7 minutes, fol-
lowed by 38 cycles of 95°C for 30 seconds, annealing at
55°C for 30 seconds, extension at 72°C for 1 minute,
and a final extension at 72°C for 7 minutes. For second-
ary PCR (to detect falciparum and/or vivax species), 3 ul
of PCR product of previous reaction was used as tem-
plate and species-specific primers set were used {rFAL1
(5’-TTA AAC TGG TTT GGG AAA ACC AAA ACC
AAATAT ATT)/rFAL2(5’-ACA CAA TGA ACT CAA
TCA TGA CTA CCC GTC-3’)a n dr V I V 1 ( 5 ’-CGC TTC
TAG CTT AAT CCA CAT AAC TGA TAC-3’)/rVIV2
(5’-ACT TCC AAG CCG AAG CAA AGA AAG TCC
TTA-3’)} in different tubes. Reaction mixture and
thermo-cycler condition was similar to primary PCR.
PCR products were analysed in agarose gel
electrophoresis.
ABO blood group typing
Blood samples of both falciparum-infected individuals
and healthy controls were typed by commercial haemag-
glutination kit (Tulip Diagnostics, Goa, India). In brief,
about 20 ul of whole blood was taken on a clean slide
and 20 ul of antisera A, B and Rhesus blood group
applied, mixed by means of an applicator stick and
results were noted.
Identification of studies for meta-analysis
An extensive PubMed search was performed for articles
published on the association of ABO blood group in
severe P. falciparum malaria. Cross-references were
checked including studies not located in PubMed. The
following key words and subject terms were searched:
ABO blood group, Plasmodium falciparum,s e v e r e
malaria and uncomplicated malaria.
Statistical analysis
Statistical analyses were performed by using GraphPad
Prism (version 5.01). Difference between means was
analysed by ANOVA. The Fisher exact test was used to
analyse the association between blood groups and severe
malaria or different clinical manifestation. Odds ratio
(OR) were calculated with 95% confidence interval. The
‘O’ blood group was taken as a reference to compare
the prevalence of other blood groups, ‘A’, ‘B’, ‘AB’ and
non ‘O’, defined as A+B+AB combined, in severe and
uncomplicated malaria. A probability value of ≤ 0.01
(0.05/4) was considered statistically significant after Bon-
ferroni correction. Meta-analysis and all related statistics
were obtained by Comprehensive Meta-analysis V2 soft-
ware. Variation within and among different study
(heterogeneity) was assessed by Q-test with the null
hypothesis that all studies have the same effects. The
random effects model was used for meta-analysis if the
Q-statistic was significant (P < 0.05) which indicate het-
erogeneity across studies. On the other hand, lineage of
all studies to null hypothesis, the fixed effect model, was
used for necessary meta-analysis.
Results
Characteristics of study participants
A total of 353 falciparum-infected patients were enrolled
in the present study, including 247 severe (SM) and 106
uncomplicated patients (UM). Severe P. falciparum
malaria patients were further subdivided into cerebral
malaria (CM) (n = 59), multi-organ dysfunction (MOD)
(n = 80) and non-cerebral severe malaria (NCSM) (n =
108). 174 healthy controls (HC) were included. The
mean age between all clinical categories and HC was
comparable. Significantly higher levels of haemoglobin
were observed in HC than UM and other clinical cate-
gories of severe malaria (P < 0.0001) (Table 1).
Distribution of ABO blood group in severe malaria,
uncomplicated malaria and healthy controls
To assess possible associations of ABO blood groups
with severe course of P. falciparum infection, prevalence
of each ABO blood group was compared in severe
malaria patients (n = 247), uncomplicated malaria (n =
106) and healthy controls (n = 174). Of the 174 blood
samples examined in healthy controls, 74 (42%), 36
(21%), 50 (29%) and 14 (8%) individuals were from O,
A, B, and AB blood group, respectively. As shown in
Table 2, prevalence of B blood group was significantly
higher in severe malaria (SM) compared to UM (P <
0.0001; OR = 4.09) and HC (P < 0.0001; OR = 2.79).
Furthermore, blood group ‘O’ was significantly asso-
ciated with UM compared to the severe categories (P <
0.0001; OR = 2.81) indicating its likely protective role
(Table 2). The distribution of blood groups among HC
and UM was comparable.
Prevalence of ABO blood group in various clinical
phenotypes of severe Plasmodium falciparum malaria
The association of ABO blood group in different clinical
phenotypes of severe malaria, categorized as CM,
NCSM and MOD, was studied. As highlighted in Table
3, prevalence of blood group ‘B’ was significantly higher
in CM (P < 0.0001; OR = 5.95), MOD (P < 0.0001; OR
= 4.81) and NCSM (P = 0.001; OR = 3.02) compared to
UM. Furthermore, the protective nature of group ‘O’
was observed when comparing its prevalence in UM vis-
a-vis the different severe groups (CM: P = 0.0003; OR =
3.77, MOD: P = 0.0002; OR = 3.31 and NCSM: P =
0.007; OR = 2.81).
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Since the study revealed a significant association of ABO
blood group and severe falciparum malaria, possible role
of ABO blood groups in disease outcome was explored.
Prevalence of blood groups were analysed among sub-
jects who died during treatment and those who survived
Out of 247 cases of severe malaria, twenty patients died
during course of treatment: five patients from CM cate-
gory (n = 59), 15 patients from MOD (n = 80) and none
from NCSM (n = 108). Therefore, NCSM patients were
not included in the analysis. Furthermore, fifteen
patients from CM and MOD groups left the hospital
against medical advice, which necessitated their exclu-
sion since their survival status was not known. As a
result, a total of 124 patients in CM and MOD groups
were analysed. Although, frequency of blood group ‘B’
was higher in patients who died (80%) compared to
those who survived (54%), the difference was not statis-
tically significant (P = 0.06). Distribution of other blood
groups in patients who died and survived was compar-
able (Table 4).
Studies included in meta-analysis
Nineteen relevant publications were identified on falci-
parum malaria and ABO blood group. The three pri-
mary criteria for inclusion in this meta-analysis were as
follows:1) study must be case-controlled, 2) patients
placed under well defined categories as severe and
uncomplicated, 3) the sample size should be more than
50 in each category. Out of nineteen studies only five
publications satisfied all inclusion criteria and were con-
sidered for meta-analysis. Data from the recent study
was also included for analysis. Table 5 shows character-
istics of all six studies.
Evaluation of publication bias
A funnel plot has been used to test publication bias in
meta-analysis. The funnel plot remains symmetric in
Table 1 Details of study participants
Subjects Severe P. falciparum malaria clinical categories (SM) UM HC P value
CM MOD NCSM
Total number (n) 59 80 108 106 174 NA
Sex (M/F) 42/17 65/15 91/17 84/22 134/40 NA
Mean age in years (range) 33.5 (15-65) 33.5 (15-70) 34 (15-65) 32.5 (15-80) 31.1 (16-75) NS
Mean Hg (g/dl)±SD 9.9 ± 1.9 9.9 ± 2.2 9.7 ± 2.5 10.82 ± 1.9 12.8 ± 1.9 < 0.0001
SM: severe malaria; CM: cerebral malaria; MOD: multi-organ dysfunction; NCSM: non-cerebral severe malaria; UM: uncomplicated malaria; HC: healthy control; NA:
not applicable; NS: not significant
Table 2 Prevalence of ABO blood group in different P. falciparum malaria clinical categories and healthy controls
Blood group SM
(n = 247)
UM
(n = 106)
HC
(n = 174)
SM vs UM P value, OR
(95% CI)
SM vs HC P value, OR
(95% CI)
UM vs HC P value, OR
(95% CI)
O 63 (25) 52 (49) 74 (42) ref ref ref
A 48 (19) 20 (19) 36 (21) 0.04, 0.50 (0.26 to 0.95) 0.12, 0.63 (0.36 to 1.10) 0.51, 1.26 (0.65 to 2.42)
B 119 (49) 24 (23) 50 (29) <0.0001, 4.09 (2.30 to 7.25) <0.0001, 2.79 (1.74 to 4.47) 0.23, 1.46 (0.80 to 2.67)
AB 17 (7) 10 (9) 14 (8) 0.52, 0.71 (0.30 to 1.69) 0.42, 0.70 (0.32 to 1.53) 1.00, 0.98 (0.40 to 2.38)
Non O (A+B+AB) 184 (75) 54 (51) 100 (58) <0.0001, 2.81 (1.74 to 4.52) 0.0003, 2.16 (1.42 to 3.27) 0.32, 1.30 (0.80 to 2.11)
NOTE: Data are no. (%) of participants unless otherwise specified.
SM: severe malaria; UM: uncomplicated malaria; HC: healthy controls; OR: odds ratio; CI: confidence interval
Table 3 Distribution of ABO blood group in different clinical subtypes of severe falciparum infections and
uncomplicated malaria
Blood group CM
(n=59)
MOD
(n=80)
NCSM
(n=108)
UM
(n=106)
CM vs UM
P value, OR
(95%CI)
MOD vs UM
P value, OR
(95%CI)
NCSM vs UM
P value, OR
(95%CI)
O 12 (20) 18 (22) 33 (31) 52 (49) ref ref ref
A 7 (12) 19 (24) 22 (20) 20 (19) 0.57, 0.65 (0.22 to 1.91) 0.02, 0.36 (0.15 to 0.83) 0.18, 0.57 (0.27 to 1.21)
B 33 (56) 40 (50) 46 (43) 24 (23) <0.0001, 5.95 (2.62 to 13.52) <0.0001, 4.81 (2.30 to 10.06) 0.001, 3.02 (1.56 to 5.83)
AB 7 (12) 3 (3) 7 (6) 10 (9) 0.10, 0.32 (0.10 to 1.04) 1.00, 1.15 (0.28 to 4.66) 1.00, 0.90 (0.31 to 2.61)
Non O (A+B+AB) 47 (80) 62 (78) 75 (69) 54 (51) 0.0003, 3.77 (1.80 to 7.90) 0.0002, 3.31 (1.73 to 6.34) 0.0078, 2.81 (1.25 to 3.82)
NOTE: Data are no. (%) of participants unless otherwise specified.
CM: cerebral malaria; MOD: multi-organ dysfunction; NCSM: non-cerebral severe malaria; UM: uncomplicated malaria; OR: odds ratio; CI: confidence interval
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groups the funnel plots were symmetric. However,
plot for blood group ‘A’ was asymmetric. Trim-and-
fill technique was used to adjust publication bias of
blood group ‘A’, for recomputing the effect size [23].
Association of ABO blood group and severe malaria
Heterogeneity Q test was performed to evaluate inter-
and intra-study variations and based upon significance
value; different models were used for the meta-analysis.
Blood group ‘O’ (P < 0.0001), ‘B’ (P = 0.004) and ‘AB’ (P
= 0.037) showed significant heterogeneity and, therefore,
a random-affect model was employed. On the other
hand, a fixed-effect model was used for association of
blood group ‘A’ since the Q-test was not significant (P =
0.120).
Results of meta-analysis are shown in Figure 1. Protec-
tion against severe malaria was significantly associated
with blood group ‘O’ (P = 0.01). In contrast, blood
group ‘A’ and ‘AB’ showed significant association to sus-
ceptibility (’A’:P=0 . 0 4a n d‘AB’: P = 0.04). Although,
‘B’ blood group was significantly associated with severe
malaria in the present study, the meta-analysis failed to
corroborate that association.
Discussion
R e s u l t so ft h ec u r r e n ts t u d ys u g g e s tt h a tp a t i e n t sw i t h
blood group ‘B’ have a four-fold increased risk of devel-
oping severe infection. In addition, it also reiterates the
observation that ‘O’ blood group was significantly asso-
ciated with a decreased risk of severe malaria. Other
blood groups (’A’ and ‘AB’) did not show any association.
T h er o l eo fA B Ob l o o dg r o u pi nm a l a r i ah a sb e e n
investigated in various populations, but robust data is
limited [24]. This study was an attempt to analyse the
association of ABO blood group in large number of
adult patients and healthy controls in Odisha, a state,
highly endemic for falciparum infection [18]. Higher
Table 4 Association of ABO blood group in treatment
outcome patients with severe malaria
Blood group Dead
(n = 20)
Survivors
(n = 104)
P value, OR (95%CI)
O 1 (5) 21 (20) ref
A 2 (10) 18 (17) 0.59, 0.42 (0.03 to 5.12)
B 16 (80) 56 (54) 0.06, 6.00 (0.74 to 48.13)
AB 1 (5) 9 (9) 0.53, 0.42 (0.02 to 7.63)
Non O (A+B+AB) 19 (95) 83 (80) 0.12, 0.20 (0.02 to 1.64)
NOTE: Data are no. (%) of participants unless otherwise specified;
OR: odds ratio; CI: confidence interval
Table 5 Characteristics of individual studies summarized for the meta-analysis
Author, Year [Ref] Population Sample Blood Groups
OA B A B
Al-Yaman et al. 1995 [34] Papua New Guinea SM
(n = 97)
44 (45) 29 (30) 10 (10) 14 (15)
UM
(n = 156)
53 (34) 55 (35) 28 (18) 20 (13)
Lell et al. 1999 [13] Gabon SM
(n = 100)
54 (64) 27 (27) Data not available Data not available
UM
(n = 100)
64 (64) 11 (11) Data not available Data not available
Pathirana et al. 2005 [12] Sri Lanka SM
(n = 80)
19 (24) 26 (32.5) 22 (27.5) 13 (16)
UM
(n = 163)
78 (48) 40 (24) 37 (23) 8 (5)
Rowe et al. 2007 [11] Mali SM
(n = 124)
26 (21) 40 (32) 11 (9) 47 (38)
UM
(n = 124)
55 (44) 31 (25) 9 (7) 29 (24)
Tekeste et al. 2010 [1] Ethiopia SM
(n = 70)
16 (23) 25 (36) 15 (21) 14 (20)
UM
(n = 140)
64 (46) 42 (30) 23 (16) 11 (8)
Current study India SM
(n = 247)
63 (25) 48 (19) 119 (49) 17 (7)
UM
(n = 106)
52 (49) 20 (19) 24 (23) 10 (9)
NOTE: Data are no. (%) of participants unless otherwise specified.
SM: severe malaria; UM: uncomplicated malaria;
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plicated cases, an indication of its possible protective
property against severity as indicated in previous reports
[1,11-13]. The mechanism of protection is not clearly
understood. It is postulated that the phenomenon of
rosetting is one of the mechanisms that contributes to
disease severity [2]. This rosetting capacity varies among
different blood groups [3]. Lowest rosette formation is
observed in blood group ‘O’ individuals. This study also
clearly highlights the association of severe malaria with
Figure 1 Forest plots of blood groups in association to severe malaria. Meta-analysis was performed including previous reports and current
study by comprehensive meta-analysis software. Random or fixed model of meta-analysis was employed for calculation of the combined effect
of all studies. Forrest plots evaluating resistance/risk factor of blood group O (I), A (II), B (III) and AB (IV) to severe malaria are shown.
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across all grades of severity. Although the number of
patients who died (n = 20) was small, frequency of
blood group ‘B’ was higher in these subjects (80%) in
comparison to survivors (54%). Previously, studies on
patients from Zimbabwe [14], Gabon [13] and Ethiopia
[ 1 ]s h o w e das i g n i f i c a n ta s s o c i a t i o no f‘A’ blood group
with severe malaria. Blood group ‘AB’ has also been
reported to be associated with severity in Sri Lanka [12],
Mali [11] and Ethiopian populations [1]. There are no
reports implicating blood group ‘B’ with severity. The
variability of observations made with regard to different
blood groups may be attributable to different rosetting
capacity, heterogenous population groups and varied
infective strains [3]. Blood group ‘A’ in Uganda and
Gambia [4,7], ‘B’ g r o u pi nT h a i l a n d[ 4 ]a n d‘AB’ group
in Kenya [6] have been associated with increased roset-
ting phenomenon.
It is presumed that the prevalence of blood group ‘O’
would be higher in malaria endemic areas due to its
capacity to confer protection. An analysis of blood
group in healthy controls revealed a distribution of ‘O’
(42%), which was much higher compared to ‘A’ (21%),
‘B’ (29%) and ‘AB’ (8%). A community-based study in a
tribal population of Odisha, where malaria is endemic,
also showed higher prevalence of blood group ‘O’ [25].
Significantly, a lower prevalence ‘O’ blood group has
been observed in other malaria non-endemic states like
Maharashtra [26,27] and Uttar Pradesh [28] in India,
indicating a selective advantage of this blood group in
endemic localities. This hypothesis is further supported
by higher prevalence of ‘O’ blood group worldwide
where malaria infection is prevalent [29].
Meta-analysis combines results of several similar stu-
d i e st op r o d u c eas i n g l ee s t i m a t eo ft h em a j o re f f e c t
with enhanced precision [30]. Current analysis revealed
significant association of blood group ‘O’ with protec-
tion against severe malaria (OR = 0.45) In contrast,
blood groups ‘A’ and ‘AB’ were associated with suscept-
ibility to severity: Blood group ‘A’ and ‘AB’ conferred
1.27- and 1.74- fold higher risks respectively. Although
in the current study, ‘B’ blood group was significantly
associated with severe malaria on meta-analysis the
association was insignificant. This variation may be a
population specific phenomenon.
There are however limitations in the present study.
Several RBC polymorphisms, including those linked to
glucose-6-phosphate dehydrogenase, pyruvate kinase,
complement receptor-1 and haemoglobinopathies, have
a role in the clinical outcome of malaria [31], but were
not included for analysis in the present study. Such
polymorphisms have only been reported from the Wes-
tern belt of Odisha among tribal communities [32,33]
and not in areas from which patients and HC in the
current study were enrolled.
Conclusion
This study reveals a significant association of blood
group ‘B’ to severe malaria. The association is valid
across all grades of severity. Blood group ‘O’ confers
protection to severe disease. The meta-analysis reiterates
the observation of protection conferred by blood group
‘O’ and highlights susceptibility of group ‘Aa n d‘AB’ to
severe malarial infection.
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